
Global Bioanalysis
Start local. Go global.
Through Crux Biolabs’ alliance with KCAS Bio, sponsors can access harmonised spectral flow cytometry across participating laboratories in Australia, the United States and Europe. Work directly with our Melbourne-based scientific and project teams, with aligned platforms, processes and oversight designed to support multi-region clinical programs.
From assay strategy and method transfer through to study delivery, Crux Biolabs provides the local access and scientific partnership you need, backed by a coordinated international network.
The Crux Biolabs + KCAS Bio advantage
Crux Biolabs is KCAS Bio’s APAC partner in a harmonised spectral flow cytometry network spanning Australia, the United States and Europe. This gives sponsors local scientific access in Melbourne, supported by aligned platforms, processes and expertise across participating laboratories.
How harmonisation works
Designed for cross-region consistency
Harmonisation is more than using comparable instruments. Across participating laboratories, the network uses aligned Cytek Aurora platforms, documented instrument setup and performance-qualification processes, and cross-site comparison activities to support a consistent approach.
Aligned procedures, worksheets, reagents and control materials, together with central planning and quality oversight, help support robust method transfer and multi-region study delivery.
Coordinated delivery
One plan. Connected teams.
For multi-region programs, sponsors can benefit from a single analytical plan, aligned data-transfer processes and coordinated scientific and project oversight. You retain direct access to the relevant site teams, while working within a connected delivery model.
This approach helps reduce handovers and complexity as your program moves between regions.